Pressmeddelanden
REG
MAR
PILA PHARMA'S BOARD OF DIRECTORS ANNOUNCES COMPLETION OF A FULLY SUBSCRIBED DIRECTED ISSUE OF APPROXIMATELY SEK 10 MILLION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAN...
REG
MAR
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
PILA PHARMA AB (publ) (FN STO:PILA) today announces it has entered into agreement with a United Kingdom based clinical research organisation, Lindus Health, on supply of clinica...
REG
MAR
PILA PHARMA'S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A DIRECTED ISSUE OF SHARES OF APPROXIMATELY SEK 10.0 MILLION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAN...
Clarification: PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE
Dispatch missing first section with scientific meeting information.
PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on D...
PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE
PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on Diabetes and Nutrition, organized by the Diabetes and Nutrition Study...
PILA PHARMA PRESENTS TOMORROW AT "AKTIESPARARNA"
PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present tomorrow at the Aktiespararna's "Store Aktiedagarna" event.
Rapporter
Video
Finansiell kalender
Halvårsrapport 2024
Delårsrapport
Bokslutskommuniké 2024
Bokslutskommuniké
Om PILA PHARMA
Webbplats
pilapharma.com
Prenumerera
Få löpande information från PILA PHARMA via e-post.
Handelsinformation
Kurs ()
Förändring ()